|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 185.68 USD | +1.45% |
|
+6.15% | +101.98% |
| 01:52pm | ASTRAZENECA : Gets a Buy rating from Jefferies | ZD |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Consensus AstraZeneca PLC
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
